TCI Wealth Advisors, Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$3,478
-13.0%
119
-13.1%
0.00%
-100.0%
Q3 2022$4,0000.0%137
+39.8%
0.00%0.0%
Q2 2022$4,000
+300.0%
98
+600.0%
0.00%
Q3 2018$1,0000.0%140.0%0.00%
Q2 2018$1,0000.0%140.0%0.00%
Q1 2018$1,0000.0%140.0%0.00%
Q4 2017$1,0000.0%140.0%0.00%
Q3 2017$1,0000.0%140.0%0.00%
-100.0%
Q2 2017$1,0000.0%140.0%0.00%0.0%
Q1 2017$1,0000.0%140.0%0.00%0.0%
Q4 2016$1,0000.0%140.0%0.00%0.0%
Q3 2016$1,0000.0%140.0%0.00%0.0%
Q2 2016$1,000140.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 112,666$1,7770.65%
Smith, Graham & Co., Investment Advisors, LP 273,099$4,306,7710.54%
BRANDES INVESTMENT PARTNERS, LP 1,134,363$17,888,9040.35%
TANG CAPITAL MANAGEMENT LLC 118,857$1,874,3750.26%
Virtus Investment Advisers, Inc. 20,867$329,0730.22%
DENALI ADVISORS LLC 32,300$509,3710.18%
Nebula Research & Development LLC 11,473$180,9290.10%
SCOUT INVESTMENTS, INC. 131,192$1,995,4300.05%
XTX Topco Ltd 15,050$237,3390.04%
PDT Partners, LLC 19,745$311,3790.04%
View complete list of EAGLE PHARMACEUTICALS INC shareholders